TrialNaunyn-Schmiedeberg's archives of pharmacology2026

Efficacy and safety of vunakizumab between super responders and non-super responders of patients with moderate-to-severe plaque psoriasis: a post-hoc exploratory analysis of a phase III trial.

Ougen Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.